Skip to content
Nonprofiteer
← SCLERODERMA RESEARCH FOUNDATION

Form 990 for tax year 2023

Filed by SCLERODERMA RESEARCH FOUNDATION.

Totals

Total revenue
$8,418,038
Total expenses
$6,487,599
Contributions and grants received
$3,932,952
Grants paid
$2,482,921
Program service revenue
$3,832,233
Investment income
$904,546
Other revenue
-$251,693
Total assets, end of year
$18,654,748
Total liabilities, end of year
$7,122,391
Net assets or fund balances, end of year
$11,532,357
Program services expenses (Part IX)
$5,614,945
Management and general expenses
$476,726
Fundraising expenses
$395,928
Program service expenses (Part III)
$5,614,945

Program services were 86.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $26,279

  • 1c · Fundraising events

    $1,141,288

  • 1f · All other contributions, gifts and grants

    $2,765,385

  • 1g · Noncash contributions included above

    $423,912

  • 2a · Program service revenue: Clinical trial platform

    total $3,832,233 · related or exempt $3,832,233

  • 3 · Investment income

    total $904,546 · excluded $904,546

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6d · Net rental income or loss

    total $0

  • 7d · Net gain or loss

    total $0

  • 8a · Fundraising events: gross income

    $93,400

  • 8a · Fundraising events: contributions included on line 1c

    $1,141,288

  • 8b · Fundraising events: direct expenses

    $352,348

  • 8c · Net income from fundraising events

    total -$258,948

  • 9c · Net income from gaming

    total $0

  • 10c · Net income from sales of inventory

    total $0

  • 11a · Other revenue: Other income

    total $7,255 · excluded $7,255

  • 11e · Other revenue, total

    $7,255

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $2,482,921 · program services $2,482,921

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $204,561 · program services $122,737 · management and general $61,368 · fundraising $20,456

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $592,227 · program services $369,514 · management and general $62,340 · fundraising $160,373

  • 8 · Pension plan contributions

    total $0

  • 9 · Other employee benefits

    total $37,801 · program services $21,632 · management and general $6,282 · fundraising $9,887

  • 10 · Payroll taxes

    total $56,839 · program services $35,145 · management and general $8,503 · fundraising $13,191

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $298,892 · program services $298,892

  • 11c · Fees: accounting

    total $236,971 · management and general $236,971

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $40,277 · management and general $40,277

  • 11g · Fees: other

    total $1,831,562 · program services $1,784,379 · management and general $24,664 · fundraising $22,519

  • 12 · Advertising and promotion

    total $182,044 · program services $140,141 · management and general $8,546 · fundraising $33,357

  • 13 · Office expenses

    total $93,632 · program services $44,929 · management and general $7,669 · fundraising $41,034

  • 14 · Information technology

    total $98,241 · program services $39,390 · management and general $8,662 · fundraising $50,189

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $84,773 · program services $50,864 · management and general $8,477 · fundraising $25,432

  • 17 · Travel

    total $17,412 · program services $4,559 · management and general $584 · fundraising $12,269

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $207,214 · program services $206,501 · management and general $162 · fundraising $551

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $13,978 · program services $8,388 · management and general $1,396 · fundraising $4,194

  • 23 · Insurance

    total $8,254 · program services $4,953 · management and general $825 · fundraising $2,476

  • 24e · All other expenses

    total $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,489,493 · end of year $3,921,428

  • 2 · Savings and temporary cash investments

    beginning of year $174 · end of year $12,296

  • 3 · Pledges and grants receivable

    beginning of year $1,207,075 · end of year $1,071,849

  • 4 · Accounts receivable

    end of year $0

  • 5 · Loans and receivables from officers and key people

    end of year $0

  • 6 · Loans and receivables from disqualified persons

    end of year $0

  • 7 · Other notes and loans receivable

    end of year $0

  • 8 · Inventories for sale or use

    end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $38,910 · end of year $56,574

  • 10a · Land, buildings and equipment: cost or other basis

    $88,950

  • 10b · Land, buildings and equipment: accumulated depreciation

    $57,321

  • 10c · Land, buildings and equipment, net

    beginning of year $45,607 · end of year $31,629

  • 11 · Investments: publicly traded securities

    beginning of year $8,215,407 · end of year $13,488,695

  • 12 · Investments: other securities

    end of year $0

  • 13 · Investments: program-related

    end of year $0

  • 14 · Intangible assets

    end of year $0

  • 15 · Other assets

    beginning of year $146,971 · end of year $72,277

  • 17 · Accounts payable and accrued expenses

    beginning of year $775,777 · end of year $2,842,768

  • 18 · Grants payable

    beginning of year $20,000

  • 19 · Deferred revenue

    beginning of year $287,435 · end of year $300,849

  • 25 · Other liabilities

    beginning of year $157,658 · end of year $3,978,774

  • 27 · Net assets without donor restrictions

    beginning of year $8,984,292 · end of year $11,531,310

  • 28 · Net assets with donor restrictions

    beginning of year $918,475 · end of year $1,047

Mission and programs · 2023

Mission

The mission of the Scleroderma Research Foundation is to fund and facilitate the most promising, highest quality research aimed at new treatments and, ultimately, a cure for scleroderma

Activities or mission (Part I)

The SRF is laser-focused on finding a cure for scleroderma by raising critical funds for research investments, fostering collaboration among the worlds top scientists and institutions to drive innovation, and raising awareness about this rare disease.

  • The SRF Research Program: Led by a Scientific Advisory Board comprised of some of the most highly regarded scientists in the nation, the SRFs research program actively seeks out and recruits experts from the fields of rheumatology, immunology, genetics, and fibrosis, as well as, experts in cutting-edge technologies to join the scleroderma research community. With an intense focus on identifying projects and investigators likely to move scleroderma research forward, the SRF funds a diverse portfolio of projects led by top-tier investigators.

    Expenses $3,547,920 · Grants $2,482,921

  • CONQUEST is a global, perpetual, clinical trial platform developed by the SRF in coordination with partner biopharmaceutical companies to accelerate the clinical development of agents for scleroderma. CONQUEST is designed to rapidly advance promising treatments for scleroderma and to identify those agents that should progress from phase 2b to phase 3 clinical trials. CONQUEST will make an enduring contribution to the scleroderma community by creating an ecosystem designed to enable rapid and efficient development of novel drugs for scleroderma patients.

    Expenses $1,513,167 · Revenue $3,832,233

  • SRF Education & Awareness Program: Many patients hear the word scleroderma for the first time when they are diagnosed. We strive to raise awareness and provide educational resources because lack of awareness about scleroderma often causes delays in treatment or misdiagnosis. As an innovator in scleroderma research, the SRF is uniquely qualified to provide those living with this disease, the medical community, and the general public with the most up-to-date, trusted and relevant news and information about complications, treatments, and related research through our website, webinars, annual patient forum, and monthly eNewsletter. And we deliver stories of impact that connect and inspire patients, as well as address issues related to diversity, equity, and inclusion that patients may encounter as they navigate diagnosis, treatment, and living with the disease.

    Expenses $553,858

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Joanne Gold

    Executive Dir.

    Total calculated
    $206,500
    From this org
    $203,286
    From related orgs
    $0
    Other
    $3,214
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $184,786
    Bonus
    $18,500
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $3,214
    Filer's total
    $206,500
  • Kate Ceredona

    Dir Philanthropy

    Total calculated
    $158,831
    From this org
    $152,315
    From related orgs
    $0
    Other
    $6,516
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $148,315
    Bonus
    $4,000
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    $6,516
    Filer's total
    $158,831
  • Gloria Blecha

    Sr Dir Comm O & Ed

    Total calculated
    $140,828
    From this org
    $129,705
    From related orgs
    $0
    Other
    $11,123
    Hours/week
    40
  • Hannah Young

    Dir Communications

    Total calculated
    $116,243
    From this org
    $110,376
    From related orgs
    $0
    Other
    $5,867
    Hours/week
    40
  • Luke Evnin PhD

    Chairman

    Total calculated
    $0
    Hours/week
    30
  • Deann Wright

    Secretary

    Total calculated
    $0
    Hours/week
    10
  • Susan Feniger

    Treasurer

    Total calculated
    $0
    Hours/week
    10
  • Omar Baker MD

    Board Member

    Total calculated
    $0
    Hours/week
    2
  • Sharon Dobie MD

    Board Member

    Total calculated
    $0
    Hours/week
    2
  • Eric Kau MD

    Board Member

    Total calculated
    $0
    Hours/week
    2
  • David Knoller

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • Violetta Merin

    Board Member

    Total calculated
    $0
    Hours/week
    2
  • Caryn Zucker

    Board Member

    Total calculated
    $0
    Hours/week
    1
  • Regina Hall

    Board Member

    Total calculated
    $0
    Hours/week
    2
  • Jeff Seaman

    Board Member

    Total calculated
    $0
    Hours/week
    2

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Written employment contract
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Provenance

Return type
form_990
Tax year
2023
Filed
28 August 2024
IRS schema version
2023v5.1
Source object
202402419349301810

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.